BMJ open

ChemMedChem

stem cell research & therapy

Biotechnic & histochemistry : official publication of the Biological Stain Commission

[1] Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90-CREB pathway.

[2] Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats.

[3] Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.

[4] artemisinin and its synthetic derivatives as a possible therapy for cancer

[5] synthetic approaches to mono- and bicyclic perortho-esters with a central 1,2,4-trioxane ring as the privileged lead structure in antimalarial and antitumor-active peroxides and clarification of the peroxide relevance

[6] approaches and recent developments for the commercial production of semi-synthetic artemisinin

[7] detailed phytochemical analysis of high- and low artemisinin-producing chemotypes of artemisia annua

[8] artemisinin prevents glutamate-induced neuronal cell death via akt pathway activation

[9] artemisinin anti-malarial drugs in china

[10] the plasmodium berghei rc strain is highly diverged and harbors putatively novel drug resistance variants

[11] artemisinin: a panacea eligible for unrestrictive use?

[12] The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells

[13] Identification of HSP90 as a direct target of artemisinin for its anti-inflammatory activity via quantitative chemical proteomics.

[14] Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

[15] Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

[16] Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

[17] Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

[18] Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

[19] Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

[20] Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

[21] Cohort event monitoring of patients treated for uncomplicated malaria with artemisinin-based combination therapies in selected hospitals and community pharmacies in Nigeria.

[22] Artemisinin-based combination therapy: knowledge and perceptions of patent medicine dealers in Owerri Metropolis, Imo State, Nigeria and implications for compliance with current malaria treatment protocol.

[23] Assessment of the haematological profile of children with malaria parasitaemia treated with three different artemisinin-based combination therapies

[24] Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania

[25] High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.

[26] Efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a protocol for systematic review and individual patient data (IPD) meta-analysis.

[27] Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania

[28] Village malaria worker performance key to the elimination of artemisinin-resistant malaria: a Western Cambodia health system assessment.

[29] Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90-CREB pathway.

[30] Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats.

[31] [The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-α and IL-6 Expression in Bronchial Epithelial Cells].

[32] Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzania: A study protocol for a controlled randomised trial.

[33] Synthesis of Novel G Factor or Chloroquine-Artemisinin Hybrids and Conjugates with Potent Antiplasmodial Activity.

[34] Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

[35] Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum

[36] Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa

[37] artemisinin and its synthetic derivatives as a possible therapy for cancer

[38] nevirapine-based antiretroviral therapy impacts artesunate and dihydroartemisinin disposition in hiv-infected nigerian adults

[39] adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria: a systematic review and meta-analysis

[40] deteksi dan spesiasi parasit malaria sampel monitoring pengobatan dihydroartemisinin-piperaquine di kalimantan dan sulawesi: mikroskopis vs polymerase chain reaction

[41] approaches and recent developments for the commercial production of semi-synthetic artemisinin

[42] detailed phytochemical analysis of high- and low artemisinin-producing chemotypes of artemisia annua

[43] overexpression of aawrky1 leads to an enhanced content of artemisinin in artemisia annua

[44] artemisinin prevents glutamate-induced neuronal cell death via akt pathway activation

[45] comparison of health service utilization for febrile children before and after introduction of malaria rapid diagnostic tests and artemisinin-based combination therapy in rural papua new guinea

[46] artemisinin anti-malarial drugs in china

[47] artemisinin: a panacea eligible for unrestrictive use?

[48] aaein3 mediates the downregulation of artemisinin biosynthesis by ethylene signaling through promoting leaf senescence in artemisia annua

[49] plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies

[50] synthesis and antimalarial activity of novel dihydro-artemisinin derivatives

[51] artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in uganda.

[52] The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells

[53] Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells

[54] A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria

[55] Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients